Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID03024671

Epicutaneous Testing of Cosmetic Products to Determine Skin Compatibility

Led by Insel Gruppe AG, University Hospital Bern · Updated on 2024-11-19

180

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

Sponsors

I

Insel Gruppe AG, University Hospital Bern

Lead Sponsor

M

Mibelle AG

Collaborating Sponsor

AI-Summary

What this Trial Is About

Researchers are studying the skin compatibility of cosmetic products by testing for potential irritants and allergic reactions. This trial focuses on adults with skin conditions who undergo patch testing to identify whether cosmetics cause skin irritation or allergies. The study is led by Insel Gruppe AG, University Hospital Bern, and aims to assess the safety of new or reformulated cosmetics for people with dermatitis. Participants will receive a patch test where a cosmetic product is applied to their back to observe skin reactions. This procedure helps to detect allergic or irritant responses. The study does not use a control or placebo group and does not involve masking or blinding. During the study, participants will be monitored for positive skin reactions to the patch test over a period of four weeks. Researchers will track the number of patients showing allergic or irritant responses. Participants must avoid certain medications and skin treatments before testing and will be followed to ensure accurate results and safety throughout the trial.

CONDITIONS

Brief Title

Epicutaneous Testing of Cosmetics for Skin Compatibility

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Men and women older than 18 years old
  • Persons undergoing a diagnostic patch test for reason of a skin disease
  • Signed written informed consent
Not Eligible

You will not qualify if you...

  • Acute skin inflammation and eczema on the back
  • Systemic corticosteroid and immunosuppressive therapy as well as UV exposure of the back within the last 4 weeks
  • Topical corticosteroids used on the back within the last two weeks

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

Treatment

Duration - 4 weeks

Participants have a test patch with the cosmetic product applied to the back to assess skin compatibility.

1 visit (in-person)

Trial Site Locations

Total: 1 location

1

Inselspital Bern

Bern, Switzerland

Actively Recruiting

Loading map...

Research Team

D

Dagmar Simon, MD

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Similar Trials

A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-c...

Atopic Dermatitis

Actively Recruiting

85 locations

The Real-world Treatment Patterns and Clinical Outcomes in M...

Dermatitis, Atopic

Actively Recruiting

8 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here